Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy

BACKGROUND: Compound Xueshuantong capsule (CXC) and Hexuemingmu tablet (HXMMT) are two important Chinese patent medicines (CPMs) frequently used to treat proliferative diabetic retinopathy (PDR), especially when complicated with vitreous hemorrhage (VH). However, a network pharmacology approach to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Hongyan, Xin, Danli, Zhan, Zongyi, Li, Zijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954618/
https://www.ncbi.nlm.nih.gov/pubmed/33747106
http://dx.doi.org/10.1155/2021/6642600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954618/
https://www.ncbi.nlm.nih.gov/pubmed/33747106
http://dx.doi.org/10.1155/2021/6642600

Ejemplares similares